Drug Type Small molecule drug |
Synonyms Alto, Ascophyllum, Sodium alginate (JAN/NF) + [4] |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Japan (26 Jun 2009), |
Regulation- |
Molecular FormulaC15H18ClN3O |
InChIKeyUFNOUKDBUJZYDE-UHFFFAOYSA-N |
CAS Registry94361-06-5 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| D03336 | - | - | - |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Duodenal Ulcer | Japan | 26 Jun 2009 | |
| Erosive gastritis | Japan | 26 Jun 2009 | |
| Esophagitis, Peptic | Japan | 26 Jun 2009 | |
| Hemorrhage | Japan | 26 Jun 2009 | |
| Stomach Ulcer | Japan | 26 Jun 2009 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Dyspepsia | Phase 3 | China | 05 Jun 2013 | |
| Erosive gastro-esophageal reflux disease | Phase 3 | China | 05 Jun 2013 | |
| Gastroesophageal Reflux | Phase 3 | China | 05 Jun 2013 | |
| Gastroesophageal Reflux | Phase 3 | China | 05 Jun 2013 |
Phase 3 | 1,107 | (Sodium Alginate Double Action Chewable Tablets) | wwaactadoo(vukqucvftr) = pafrhwufms rqfcjsaslo (imrjyjquim, tutslbpbbn - qpixcjcyqf) View more | - | 13 Mar 2025 | ||
Matching placebo tablets (Matching Placebo Tablets) | wwaactadoo(vukqucvftr) = ydshckgjei rqfcjsaslo (imrjyjquim, dymucwcwek - zvoockyzxb) View more |





